Condition

Ductal Carcinoma

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions11

Lead sponsors shown5

Clinical trials

5 shown

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast CancerNCT07499999 · 2026-09-09

NOT_YET_RECRUITING

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast CancerNCT02779855 · 2017-05-02

Intraoperative Imaging of Breast Cancer With Indocyanine GreenNCT01796041 · 2011-07-01

Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and ReconstructionNCT01208974 · 2010-03-16

Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerNCT00461344 · 2004-07-01

Common interventions

Axillary SurgeryPROCEDURE1 Breast ReconstructionPROCEDURE1 DocetaxelDRUG1 DoxorubicinDRUG1 ExemestaneDRUG1 Indocyanine GreenDRUG1 Nipple-Sparing MastectomyPROCEDURE1 PaclitaxelDRUG1 Prophylactic Nipple-Areolar Complex RTRADIATION1 Talimogene laherparepvecBIOLOGICAL1 TamoxifenDRUG1

Leading sponsors

Abramson Cancer Center at Penn Medicine1 Dana-Farber Cancer Institute1 H. Lee Moffitt Cancer Center and Research Institute1 Sanofi1 University of Miami1

Trial status mix

COMPLETED3

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

PHASE23

EARLY_PHASE11

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.